Rici Healthcare Holdings Ltd. (1526) AI Stock Analysis

• Market Cap: HK$1.70B
• Dividend Yield: 4.21%
• Average Volume (3M): 80.37K
• Price to Earnings (P/E): 5.3
• Beta (1Y): 0.39
• Revenue Growth: -3.85%
• EPS Growth: -19.28%
• Country: HK
• Employees: 8,908
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Care Facilities
• EPS (TTM): 0.20
• Shares Outstanding: 1,590,324,000
• 10 Day Avg. Volume: 82,700
• 30 Day Avg. Volume: 80,366
• PEG Ratio: -0.53
• Price to Book (P/B): 1.18
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -41.27
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 68 Neutral
• Price Target: HK$1.00 ▼(-6.54%Downside)

Rici Healthcare Holdings Ltd. is financially stable with strong profitability and an attractive valuation, highlighted by a low P/E ratio and high dividend yield. However, challenges such as revenue decline, high leverage, and zero free cash flow limit the score. Technical analysis shows neutral momentum, indicating the absence of a clear trend.

Rici Healthcare Holdings Ltd. Business Overview & Revenue Model

Company Description

Rici Healthcare Holdings Ltd. (1526) is a Chinese company primarily engaged in the provision of premium healthcare services. The company operates through three main segments: medical examination, hospital, and medical consultancy and management services. It offers a variety of healthcare services, including medical examinations, diagnosis, and treatments, focusing on providing high-quality medical and healthcare services to its clients.

How the Company Makes Money

Rici Healthcare Holdings Ltd. generates revenue through its diversified healthcare operations. The medical examination segment is a major revenue stream, providing routine and comprehensive health check-ups to individuals and corporate clients. The hospital segment contributes to earnings by offering inpatient and outpatient services, including surgical operations, medical treatments, and specialized healthcare services. Additionally, the company benefits from its medical consultancy and management services, which involve providing consultancy services to other healthcare institutions and managing healthcare facilities. Strategic partnerships and collaborations with healthcare providers and corporate clients also play a significant role in enhancing the company's revenue streams.

Rici Healthcare Holdings Ltd. Financial Statement Overview

Summary

Rici Healthcare Holdings Ltd. demonstrates strong profitability with solid profit margins and return on equity. However, revenue decline and high leverage pose risks. Cash flow management needs improvement to ensure liquidity and growth.

Income Statement

Rici Healthcare Holdings Ltd. shows a strong gross profit margin of 39.9% and a net profit margin of 10.2% for the latest year. Revenue showed a slight decline of 2.3% compared to the previous year, indicating some challenges in maintaining growth. The EBIT margin is healthy at 20.8%, and the EBITDA margin stands at 27.3%, reflecting solid operational efficiency. While profitability remains robust, the recent revenue contraction highlights the need for strategic growth initiatives.

Balance Sheet

The company's debt-to-equity ratio is relatively high at 1.71, indicating leverage that could pose risks if not managed carefully. However, the return on equity is strong at 22.1%, showing effective use of equity capital. With an equity ratio of 27.7%, the company maintains a balanced asset structure, though the high debt level suggests potential volatility in financial stability.

Cash Flow

Rici Healthcare's free cash flow is currently zero, which poses concerns about liquidity and operational cash coverage. The previous year showed a positive operating cash flow to net income ratio of 2.27, indicating healthy cash generation relative to net income in the past. The absence of free cash flow growth in the latest year suggests cash flow management may need attention to sustain operations and fund growth.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.92B	2.99B	2.38B	2.38B	1.93B
Gross Profit	1.17B	1.25B	927.20M	975.22M	580.66M
EBITDA	798.69M	1.07B	572.61M	682.80M	234.75M
Net Income	297.32M	363.80M	290.79M	349.15M	-7.88M
Balance Sheet
Total Assets	4.86B	4.64B	4.57B	4.54B	4.21B
Cash, Cash Equivalents and Short-Term Investments	1.12B	811.21M	720.14M	784.36M	574.86M
Total Debt	2.30B	2.27B	2.30B	2.74B	2.90B
Total Liabilities	3.48B	3.52B	3.66B	3.95B	3.88B
Stockholders Equity	1.35B	1.13B	953.92M	677.50M	505.81M
Cash Flow
Free Cash Flow	584.35M	487.07M	396.33M	356.41M	77.71M
Operating Cash Flow	790.58M	826.29M	706.37M	681.07M	444.63M
Investing Cash Flow	-140.02M	-147.00M	-273.99M	-269.13M	-355.44M
Financing Cash Flow	-351.23M	-592.72M	-495.23M	-193.99M	169.32M

Rici Healthcare Holdings Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.07
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Negative. The current price of 1.07 is below the 20-day moving average (MA) of 1.08, below the 50-day MA of 1.09, and below the 200-day MA of 1.17, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 46.79 is Neutral, neither overbought nor oversold. The STOCH value of 38.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1526.

Rici Healthcare Holdings Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1526	68 Neutral	HK$1.70B	5.28	24.13%	4.21%	-3.85%	-19.28%
3689	64 Neutral	HK$598.57M	36.02	1.07%	8.94%	-1.20%	-87.51%
3886	61 Neutral	HK$1.65B	―	-6.55%	0.49%	0.04%	-4.88%
Sector *	60 Neutral	HK$16.23B	5.53	-7.44%	3.84%	11.55%	-28.15%
1419	58 Neutral	HK$315.03M	14.65	2.73%	3.37%	-0.69%	―
9906	58 Neutral	HK$900.00M	24.55	5.60%	―	-0.83%	-18.97%
3869	48 Neutral	HK$718.61M	―	-10.78%	―	-0.95%	-128.35%

Rici Healthcare Holdings Ltd. Corporate Events

Rici Healthcare Updates Nomination Committee Terms

Rici Healthcare Holdings Ltd., incorporated in the Cayman Islands, has revised the terms of reference for its Nomination Committee, which is responsible for board composition and succession planning. The committee’s duties include reviewing board structure, assessing director independence, and recommending appointments to ensure alignment with corporate strategy. This revision aims to enhance governance and strategic alignment, potentially impacting the company’s leadership and operational effectiveness.

Rici Healthcare’s AGM Resolutions Unanimously Approved

Rici Healthcare Holdings Ltd. announced that all resolutions proposed at its Annual General Meeting held on June 19, 2025, were unanimously passed by its shareholders. This includes the re-election of directors, authorization for the board to fix directors’ remuneration, re-appointment of auditors, and mandates related to share allotment and repurchase, indicating strong shareholder support and a stable outlook for the company’s governance and financial strategies.

Rici Healthcare Announces AGM with Key Resolutions on Agenda

Rici Healthcare Holdings Ltd. has announced its annual general meeting scheduled for June 19, 2025, where shareholders will consider several resolutions, including the adoption of financial statements, re-election of directors, and re-appointment of the auditor. The meeting will also address granting the board authority to issue additional shares, which could impact the company’s capital structure and shareholder value.